Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease

This study has been completed.
Sponsor:
Collaborator:
Crohn's and Colitis Foundation
Information provided by (Responsible Party):
Paul Rufo, Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT00215020
First received: September 15, 2005
Last updated: January 26, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2006
  Primary Completion Date: June 2006 (Final data collection date for primary outcome measure)